Generics NewsLatest News On Generics Tariffs Won’t Secure Our Drug Supply Chain—They’ll Break It8/28/2025 6:48 PM Volume, Not Price, Fueling Rise in Part D Specialty Derm Drug Spending7/18/2025 6:54 AM Demand for Obesity Drugs Shoots Up in India as Lilly, Novo Vie for Market Share7/7/2025 4:30 PM US FDA Approves KalVista Pharma's Swelling Disorder Drug, Shares Rise7/7/2025 8:49 AM EU Approves Vertex's Next-generation Cystic Fibrosis Drug7/1/2025 10:55 AM Hologram Doctor: Not Who I’d Like to Visit, Says Ethicist6/24/2025 12:30 PM How Proposed Tariffs Could Disrupt US Drug Prices and Supply6/18/2025 10:18 AM First-Generation Anti-Obesity Medications: Overlooked Gems for Obesity Treatment5/26/2025 5:30 AM Generic Version of HIV Drug Recommended for EU5/23/2025 10:44 AM Residency Personal Statements: Why They Matter4/15/2025 9:41 AM The Era of Compounded GLP-1 Drugs Is Over. What Now?4/10/2025 3:37 AM Generic Tofacitinib: Will It Be a Bellwether for the Future of Expensive Generics?3/28/2025 1:13 PM How Can Doctors Help Patients Navigate Wild Online Market for Compounded GPL-1 Drugs?3/20/2025 6:06 AM AHA Asks for Tariff Exemptions for Medical Products, Drugs2/20/2025 6:09 AM Bristol Myers Squibb Unveils Cost-Cutting Plans and Beats Q4 Earnings Expectations2/6/2025 8:15 AM Teva Pharmaceuticals: A Dip Buying Opportunity?2/5/2025 1:26 AM Patients Before Monopolies Act: A Game Changer for Patients, Pharmacists, and Prices?1/24/2025 2:54 PM How to Start a Dialogue About Obesity With Patients1/21/2025 4:04 PM Change Makers: Richard Francis on the Pillars of Innovation and Growth1/10/2025 5:07 PM FDA Ends Shortage of Obesity Drugs, Phased Out Generics12/20/2024 1:25 AM
